Condition: Prostate Cancer · Prostate Adenocarcinoma · Benign Prostatic Hyperplasia · Sponsor: Profound Medical Inc.
This patient registry will capture data from patients who have been or who are undergoing the transurethral ultrasound ablation (TULSA) procedure as part of their routine clinical care. The registry will shed light on real-world outcomes of safety and efficacy of the procedure and understand how a patient's quality of life is affected throughout their follow-up and lifetime.
This description comes directly from the study's public registry record.
Gina Clarke · 416-689-8156 · gclarke@profoundmedical.com
Arthi Rajamohan · 647-476-1350 · arajamohan@profoundmedical.com
Always discuss trial participation with your own doctor first.
| RadNet's Liberty Pacific West Hills Facility | West Hills, California, United States | Recruiting |
| Mayo Clinic Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Wellspan Health | York, Pennsylvania, United States | Recruiting |
| University of Texas Southwestern Medical Center | Dallas, Texas, United States | Recruiting |
| Urology Place | San Antonio, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05001477